The presence of hiatal hernia is a significant predictor for symptomatic recurrence after cessation of vonoprazan therapy for gastroesophageal reflux disease: a long-term observational study.
Satoshi ShinozakiHiroyuki OsawaYoshimasa MiuraHirotsugu SakamotoYoshikazu HayashiTomonori YanoEdward J DespottHironori YamamotoPublished in: Scandinavian journal of gastroenterology (2024)
The rate of symptomatic recurrence after VPZ cessation in patients with GERD is considerable. Cessation of acid suppression therapy should be cautious in patients with both a hiatal hernia and GERD.